NEW ORLEANS – FDA’s Elektra Papadopoulos gave a clear sign that social media can be used to help validate the content of patient-reported outcomes, although she noted that a lot of work still is needed to be done before social media becomes a part of the PRO landscape.
During a May 22 panel discussion at the International Society of Pharmacoeconomics and Outcomes Research, Papadopoulos responded to the title of the session, “Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?